Psychometric testing of two new patient‐reported outcome instruments for the evaluation of treatment for hypogonadism

by Hayes, R. P., Ni, X., Heiselman, D. E., Kinchen, K.
Published 2016

Tailoring the morphological features of hydrothermally synthesized mesoporous hydroxyapatite using polyphenols and phosphate sources

by Zhou, H., Yang, M., Hou, S., Ni, X., Bi, Y., Wang, W., Kutty, M.G., Yang, L.
Published 2017

Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers

by Xu, B, Gao, L, Wang, L, Tang, G, He, M, Yu, Y, Ni, X, Sun, Y
Published 2013

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study

by Su, X, Zhan, P, Gavine, P R, Morgan, S, Womack, C, Ni, X, Shen, D, Bang, Y-J, Im, S-A, Ho Kim, W, Jung, E-J, Grabsch, H I, Kilgour, E
Published 2014

HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma

by Liu, Y J, Shen, D, Yin, X, Gavine, P, Zhang, T, Su, X, Zhan, P, Xu, Y, Lv, J, Qian, J, Liu, C, Sun, Y, Qian, Z, Zhang, J, Gu, Y, Ni, X
Published 2014